Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
This report contains market size and forecasts of Pulmonary Drug Delivery Systems in global, including the following market information:
Global Pulmonary Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pulmonary Drug Delivery Systems Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Pulmonary Drug Delivery Systems companies in 2021 (%)
The global Pulmonary Drug Delivery Systems market was valued at 3134.3 million in 2021 and is projected to reach US$ 4129.9 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nebulizers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pulmonary Drug Delivery Systems include 3M, GSK, AstraZeneca, Cipla, Chiesi, Boehringer Ingelheim, Aptar, Novartis and Philips Respironics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
- Nebulizers
- Dry Powder Inhaler (DPI)
- Metered Dose Inhaler (MDI)
Global Pulmonary Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
- COPD
- Asthma
- Others
Global Pulmonary Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Drug Delivery Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pulmonary Drug Delivery Systems revenues share in global market, 2021 (%)
Key companies Pulmonary Drug Delivery Systems sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Pulmonary Drug Delivery Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 3M
- GSK
- AstraZeneca
- Cipla
- Chiesi
- Boehringer Ingelheim
- Aptar
- Novartis
- Philips Respironics
- Omron Healthcare
- PARI
- Skyepharma
- CareFusion
- Shanghai Huarui
- Taian Character
- Chia Tai Tianqing
Pulmonary Drug Delivery Systems Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Systems Overall Market Size
2.1 Global Pulmonary Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Pulmonary Drug Delivery Systems Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pulmonary Drug Delivery Systems Sales: 2017-2028
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Systems Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Systems Revenue by Companies
3.4 Global Pulmonary Drug Delivery Systems Sales by Companies
3.5 Global Pulmonary Drug Delivery Systems Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pulmonary Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Nebulizers
4.1.3 Dry Powder Inhaler (DPI)
4.1.4 Metered Dose Inhaler (MDI)
4.2 By Type - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
4.3 By Type - Global Pulmonary Drug Delivery Systems Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Systems Sales, 2017-2022
4.3.2 By Type - Global Pulmonary Drug Delivery Systems Sales, 2023-2028
4.3.3 By Type - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
4.4 By Type - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 COPD
5.1.3 Asthma
5.1.4 Others
5.2 By Application - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
5.3 By Application - Global Pulmonary Drug Delivery Systems Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Systems Sales, 2017-2022
5.3.2 By Application - Global Pulmonary Drug Delivery Systems Sales, 2023-2028
5.3.3 By Application - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
5.4 By Application - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 By Region - Global Pulmonary Drug Delivery Systems Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Systems Sales, 2017-2022
6.3.2 By Region - Global Pulmonary Drug Delivery Systems Sales, 2023-2028
6.3.3 By Region - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.4.2 By Country - North America Pulmonary Drug Delivery Systems Sales, 2017-2028
6.4.3 US Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.4.4 Canada Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.4.5 Mexico Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.5.2 By Country - Europe Pulmonary Drug Delivery Systems Sales, 2017-2028
6.5.3 Germany Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.4 France Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.5 U.K. Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.6 Italy Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.7 Russia Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.8 Nordic Countries Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.9 Benelux Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.6.2 By Region - Asia Pulmonary Drug Delivery Systems Sales, 2017-2028
6.6.3 China Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.4 Japan Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.5 South Korea Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.6 Southeast Asia Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.7 India Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.7.2 By Country - South America Pulmonary Drug Delivery Systems Sales, 2017-2028
6.7.3 Brazil Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.7.4 Argentina Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, 2017-2028
6.8.3 Turkey Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8.4 Israel Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8.5 Saudi Arabia Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8.6 UAE Pulmonary Drug Delivery Systems Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Pulmonary Drug Delivery Systems Major Product Offerings
7.1.4 3M Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.1.5 3M Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pulmonary Drug Delivery Systems Major Product Offerings
7.2.4 GSK Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Pulmonary Drug Delivery Systems Major Product Offerings
7.3.4 AstraZeneca Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Cipla
7.4.1 Cipla Corporate Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Pulmonary Drug Delivery Systems Major Product Offerings
7.4.4 Cipla Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.4.5 Cipla Key News
7.5 Chiesi
7.5.1 Chiesi Corporate Summary
7.5.2 Chiesi Business Overview
7.5.3 Chiesi Pulmonary Drug Delivery Systems Major Product Offerings
7.5.4 Chiesi Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.5.5 Chiesi Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Major Product Offerings
7.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Aptar
7.7.1 Aptar Corporate Summary
7.7.2 Aptar Business Overview
7.7.3 Aptar Pulmonary Drug Delivery Systems Major Product Offerings
7.7.4 Aptar Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.7.5 Aptar Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Pulmonary Drug Delivery Systems Major Product Offerings
7.8.4 Novartis Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Philips Respironics
7.9.1 Philips Respironics Corporate Summary
7.9.2 Philips Respironics Business Overview
7.9.3 Philips Respironics Pulmonary Drug Delivery Systems Major Product Offerings
7.9.4 Philips Respironics Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.9.5 Philips Respironics Key News
7.10 Omron Healthcare
7.10.1 Omron Healthcare Corporate Summary
7.10.2 Omron Healthcare Business Overview
7.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Major Product Offerings
7.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.10.5 Omron Healthcare Key News
7.11 PARI
7.11.1 PARI Corporate Summary
7.11.2 PARI Pulmonary Drug Delivery Systems Business Overview
7.11.3 PARI Pulmonary Drug Delivery Systems Major Product Offerings
7.11.4 PARI Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.11.5 PARI Key News
7.12 Skyepharma
7.12.1 Skyepharma Corporate Summary
7.12.2 Skyepharma Pulmonary Drug Delivery Systems Business Overview
7.12.3 Skyepharma Pulmonary Drug Delivery Systems Major Product Offerings
7.12.4 Skyepharma Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.12.5 Skyepharma Key News
7.13 CareFusion
7.13.1 CareFusion Corporate Summary
7.13.2 CareFusion Pulmonary Drug Delivery Systems Business Overview
7.13.3 CareFusion Pulmonary Drug Delivery Systems Major Product Offerings
7.13.4 CareFusion Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.13.5 CareFusion Key News
7.14 Shanghai Huarui
7.14.1 Shanghai Huarui Corporate Summary
7.14.2 Shanghai Huarui Business Overview
7.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Major Product Offerings
7.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Huarui Key News
7.15 Taian Character
7.15.1 Taian Character Corporate Summary
7.15.2 Taian Character Business Overview
7.15.3 Taian Character Pulmonary Drug Delivery Systems Major Product Offerings
7.15.4 Taian Character Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.15.5 Taian Character Key News
7.16 Chia Tai Tianqing
7.16.1 Chia Tai Tianqing Corporate Summary
7.16.2 Chia Tai Tianqing Business Overview
7.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Major Product Offerings
7.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.16.5 Chia Tai Tianqing Key News
8 Global Pulmonary Drug Delivery Systems Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Systems Production Capacity, 2017-2028
8.2 Pulmonary Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Systems Supply Chain Analysis
10.1 Pulmonary Drug Delivery Systems Industry Value Chain
10.2 Pulmonary Drug Delivery Systems Upstream Market
10.3 Pulmonary Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pulmonary Drug Delivery Systems in Global Market
Table 2. Top Pulmonary Drug Delivery Systems Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pulmonary Drug Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pulmonary Drug Delivery Systems Revenue Share by Companies, 2017-2022
Table 5. Global Pulmonary Drug Delivery Systems Sales by Companies, (M Units), 2017-2022
Table 6. Global Pulmonary Drug Delivery Systems Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pulmonary Drug Delivery Systems Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pulmonary Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Pulmonary Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pulmonary Drug Delivery Systems Sales (M Units), 2017-2022
Table 15. By Type - Global Pulmonary Drug Delivery Systems Sales (M Units), 2023-2028
Table 16. By Application - Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pulmonary Drug Delivery Systems Sales (M Units), 2017-2022
Table 20. By Application - Global Pulmonary Drug Delivery Systems Sales (M Units), 2023-2028
Table 21. By Region - Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pulmonary Drug Delivery Systems Sales (M Units), 2017-2022
Table 25. By Region - Global Pulmonary Drug Delivery Systems Sales (M Units), 2023-2028
Table 26. By Country - North America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pulmonary Drug Delivery Systems Sales, (M Units), 2017-2022
Table 29. By Country - North America Pulmonary Drug Delivery Systems Sales, (M Units), 2023-2028
Table 30. By Country - Europe Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pulmonary Drug Delivery Systems Sales, (M Units), 2017-2022
Table 33. By Country - Europe Pulmonary Drug Delivery Systems Sales, (M Units), 2023-2028
Table 34. By Region - Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pulmonary Drug Delivery Systems Sales, (M Units), 2017-2022
Table 37. By Region - Asia Pulmonary Drug Delivery Systems Sales, (M Units), 2023-2028
Table 38. By Country - South America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pulmonary Drug Delivery Systems Sales, (M Units), 2017-2022
Table 41. By Country - South America Pulmonary Drug Delivery Systems Sales, (M Units), 2023-2028
Table 42. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, (M Units), 2017-2022
Table 45. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, (M Units), 2023-2028
Table 46. 3M Corporate Summary
Table 47. 3M Pulmonary Drug Delivery Systems Product Offerings
Table 48. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Pulmonary Drug Delivery Systems Product Offerings
Table 51. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. AstraZeneca Corporate Summary
Table 53. AstraZeneca Pulmonary Drug Delivery Systems Product Offerings
Table 54. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Cipla Corporate Summary
Table 56. Cipla Pulmonary Drug Delivery Systems Product Offerings
Table 57. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Chiesi Corporate Summary
Table 59. Chiesi Pulmonary Drug Delivery Systems Product Offerings
Table 60. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Boehringer Ingelheim Corporate Summary
Table 62. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Offerings
Table 63. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Aptar Corporate Summary
Table 65. Aptar Pulmonary Drug Delivery Systems Product Offerings
Table 66. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Pulmonary Drug Delivery Systems Product Offerings
Table 69. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Philips Respironics Corporate Summary
Table 71. Philips Respironics Pulmonary Drug Delivery Systems Product Offerings
Table 72. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Omron Healthcare Corporate Summary
Table 74. Omron Healthcare Pulmonary Drug Delivery Systems Product Offerings
Table 75. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. PARI Corporate Summary
Table 77. PARI Pulmonary Drug Delivery Systems Product Offerings
Table 78. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Skyepharma Corporate Summary
Table 80. Skyepharma Pulmonary Drug Delivery Systems Product Offerings
Table 81. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. CareFusion Corporate Summary
Table 83. CareFusion Pulmonary Drug Delivery Systems Product Offerings
Table 84. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Shanghai Huarui Corporate Summary
Table 86. Shanghai Huarui Pulmonary Drug Delivery Systems Product Offerings
Table 87. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Taian Character Corporate Summary
Table 89. Taian Character Pulmonary Drug Delivery Systems Product Offerings
Table 90. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Chia Tai Tianqing Corporate Summary
Table 92. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Offerings
Table 93. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Pulmonary Drug Delivery Systems Production Capacity (M Units) of Key Manufacturers in Global Market, 2020-2022 (M Units)
Table 95. Global Pulmonary Drug Delivery Systems Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Pulmonary Drug Delivery Systems Production by Region, 2017-2022 (M Units)
Table 97. Global Pulmonary Drug Delivery Systems Production by Region, 2023-2028 (M Units)
Table 98. Pulmonary Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 99. Pulmonary Drug Delivery Systems Market Drivers in Global Market
Table 100. Pulmonary Drug Delivery Systems Market Restraints in Global Market
Table 101. Pulmonary Drug Delivery Systems Raw Materials
Table 102. Pulmonary Drug Delivery Systems Raw Materials Suppliers in Global Market
Table 103. Typical Pulmonary Drug Delivery Systems Downstream
Table 104. Pulmonary Drug Delivery Systems Downstream Clients in Global Market
Table 105. Pulmonary Drug Delivery Systems Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pulmonary Drug Delivery Systems Segment by Type
Figure 2. Pulmonary Drug Delivery Systems Segment by Application
Figure 3. Global Pulmonary Drug Delivery Systems Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pulmonary Drug Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pulmonary Drug Delivery Systems Revenue, 2017-2028 (US$, Mn)
Figure 7. Pulmonary Drug Delivery Systems Sales in Global Market: 2017-2028 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Pulmonary Drug Delivery Systems Revenue in 2021
Figure 9. By Type - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 10. By Type - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pulmonary Drug Delivery Systems Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 13. By Application - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pulmonary Drug Delivery Systems Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 16. By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 19. US Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 24. Germany Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 25. France Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 33. China Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 37. India Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 40. Brazil Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
Figure 44. Turkey Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pulmonary Drug Delivery Systems Production Capacity (M Units), 2017-2028
Figure 49. The Percentage of Production Pulmonary Drug Delivery Systems by Region, 2020 VS 2027
Figure 50. Pulmonary Drug Delivery Systems Industry Value Chain
Figure 51. Marketing Channels
Global Pulmonary Drug Delivery Systems Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 143
According to our LPI (LP Information) latest study, the global Pulmonary Drug Delivery Systems market size was valued at US$ 2979.8 million in 2023. With growing demand in downstream market, the Pulmonary Drug Delivery Systems is forecast to a readjusted size of US$ 4016.5 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Pulmonary Drug Delivery Systems market. Pulmonary Drug Delivery Systems are expected to show s......
Global Metered Dose Inhalers Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 88
The Metered Dose Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metered Dose Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides pr......
Global Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Drug Delivery Devices market size was valued at US$ 40490 million in 2023. With growing demand in downstream market, the Drug Delivery Devices is forecast to a readjusted size of US$ 57290 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global Drug Delivery Devices market. Drug Delivery Devices are expected to show stable growth in the future market. However......
Global Nebulizers Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Nebulizers market size was valued at US$ 844.1 million in 2023. With growing demand in downstream market, the Nebulizers is forecast to a readjusted size of US$ 1194.4 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global Nebulizers market. Nebulizers are expected to show stable growth in the future market. However, product differentiation, reducing costs, ......
Global Inhalation Therapy Nebulizer Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Inhalation Therapy Nebulizer market size was valued at US$ 1111.6 million in 2023. With growing demand in downstream market, the Inhalation Therapy Nebulizer is forecast to a readjusted size of US$ 1755.2 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Inhalation Therapy Nebulizer market. Inhalation Therapy Nebulizer are expected to show stable growth......
Global Medical Nebulizer Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 112
According to our LPI (LP Information) latest study, the global Medical Nebulizer market size was valued at US$ 1082.4 million in 2023. With growing demand in downstream market, the Medical Nebulizer is forecast to a readjusted size of US$ 1836.1 million by 2030 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Medical Nebulizer market. Medical Nebulizer are expected to show stable growth in the future market. However, product diff......
Global Intrathecal Pumps Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 75
According to our LPI (LP Information) latest study, the global Intrathecal Pumps market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Intrathecal Pumps is forecast to a readjusted size of US$ 345.7 million by 2030 with a CAGR of 3.9% during review period.
The research report highlights the growth potential of the global Intrathecal Pumps market. Intrathecal Pumps are expected to show stable growth in the future market. However, product differ......
Global Intranasal Drug Delivery Devices Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Intranasal Drug Delivery Devices market size was valued at US$ 1118.1 million in 2023. With growing demand in downstream market, the Intranasal Drug Delivery Devices is forecast to a readjusted size of US$ 2382.3 million by 2030 with a CAGR of 11.4% during review period.
The research report highlights the growth potential of the global Intranasal Drug Delivery Devices market. Intranasal Drug Delivery Devices are expected to s......
Global Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 156
According to our (Global Info Research) latest study, the global Drug Delivery Devices market size was valued at USD 42590 million in 2023 and is forecast to a readjusted size of USD 58700 million by 2030 with a CAGR of 4.7% during review period.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
